Kemble George

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kemble George's trades of Sagimet Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-22 2026-07-20
PlS Planned sale
59,541 +45.3%
304.75
US$442,664 		59,541 +45.3% 304.75 US$442,664
2026-07-20 2026-07-20
PrS Proposed sale
8,444
187.12
US$3,479,678 		8,444 187.12 US$3,479,678
2025-11-21 2025-11-20
PlS Planned sale
73,108 +27.1%
252.10
US$3,066,494 		73,108 +27.1% 252.10 US$3,066,494
2025-11-20 2025-11-20
PrS Proposed sale
37,688
7.85
US$295,851 		37,688 7.85 US$295,851
2024-07-25 2024-07-23
PlS Planned sale
23,625 -16.6%
3.17
US$74,830 		23,625 -16.6% 3.17 US$74,830
2024-07-23 2024-07-23
PrS Proposed sale
23,625
3.09
US$73,001 		23,625 3.09 US$73,001
2024-07-23 2024-07-19
S Sale
14,062 -9.0%
3.10
US$43,605 		14,062 -9.0% 3.10 US$43,605